RABGGTA

Across TCGA pan-cancer cohorts, RABGGTA RNA is linked to patient survival in 19 of 34 cancer types, making it the most broadly survival-associated RABGGTA data layer compared with 5 for mutation status and 6 for mass-spec protein.

The strongest signal is observed in kidney chromophobe (KICH), where higher RABGGTA RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RABGGTA expression acts as an unfavorable survival marker, although some lineages such as MESO and THCA show a favorable association.

KICH, MESO, and ACC are the cancer types where RABGGTA RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KICH	DFS	Median	III,IV	0.065	1.000	<.001	108	view →
MESO	OS	Median	All	0.677	0.414	<.001	98	view →
ACC	DFS	Median	All	0.284	0.637	<.001	54	view →
THCA	OS	Tertile	III,IV	1.000	0.729	.003	45	view →
KIRP	DFS	Median	III,IV	0.753	0.437	.008	36	view →
STAD	DFS	Median	III,IV	0.217	0.455	.013	28	view →
UCS	OS	Tertile	III,IV	0.147	0.603	.019	26	view →
LUSC	DFS	Median	III,IV	0.544	0.767	.005	17	view →
UVM	OS	Tertile	II,III,IV	0.616	0.878	.011	15	view →
READ	OS	Tertile	II,III,IV	0.546	0.861	.011	14	view →
LAML	DFS	Median	All	0.380	0.532	.016	12	view →
ESCA	DFS	Tertile	IV	0.704	0.231	.024	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 19 lineages.

RABGGTA–KICH (DFS)

Open the KICH breakdown →